US 7001602
Use of botulinum toxin therapy for urinary incontinence and related disorders
expired A61KA61K31/165A61K31/529
Quick answer
US patent 7001602 (Use of botulinum toxin therapy for urinary incontinence and related disorders) held by The Regents of the University of Colorado expires Mon Feb 16 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- The Regents of the University of Colorado
- Grant date
- Tue Feb 21 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 16 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K31/165, A61K31/529, A61K38/1703, A61K38/4893